On the one hand, Tregs can release immunosuppressive cytokines, such as IL-35, IL-10, and transforming growth factor β (TGF-β), which inhibit the function of CD8+ T cells and promote tumor cell growth (34). The gene discussed is CD8A; the disease is neoplasm.